NEWS

Start each day with OncologySTAT’s premier medical and pharmaceutical news provided by Elsevier Global Medical News and FDC Reports.

Page 1 of 250

« start ‹ previous ... 1 2 3 4 5 ... next › end »

Adjuvant Gemcitabine Comparable to Fluorouracil for Resected Pancreatic Cancer

MA Moon, 2010 Sept 8, Elsevier Global Medical News

Gemcitabine as adjuvant chemotherapy following complete resection for pancreatic cancer did not improve overall survival when compared with standard chemotherapy with fluorouracil plus folinic acid in...

Pfizer Axes Deal for Brain Cancer Vaccine, Leaves Partner Celldex in the Lurch

E Hayes, 2010 Sept 3, The Pink Sheet Daily

Pfizer's abrupt abandonment of a development deal with Celldex for the mid-stage brain cancer vaccine CDX-110 - despite positive Phase II data backing the drug - is a blow for development of drugs to treat...

UK Study Revives Theory That Osteoporosis Drugs Cause Esophageal Cancer

E Hayes, 2010 Sept 2, The Pink Sheet Daily

A peer-reviewed study based on a massive British database has linked long-term use of oral bisphosphonate drugs to a higher risk of esophageal cancer, contrary to a separate study of the same database...

Formal Training Improves Robot-Assisted Prostatectomy Outcomes

D Mahoney, 2010 Aug 31, Elsevier Global Medical News

Formal training in robotic prostatectomy, compared with the more typical transition from laparoscopic prostatectomy done by performing on a consecutive cohort of patients, improves the pathologic and surgical...

Roche's T-DM1 Early Filing Strategy Backfires as FDA Refuses to File BLA

J Merrill, 2010 Aug 27, The Pink Sheet Daily

It hasn't been a swell summer for Roche, and now a bit of near-term pipeline news that could have put the company on a more positive trajectory has fallen flat. FDA refused to file Roche's BLA for breast...

Light Sciences Oncology Takes Quiet Path in Developing its New Cancer Medicine

J Haas, 2010 Aug 27, The Pink Sheet Daily

For a company many in the industry probably haven't heard of, Light Sciences Oncology has big ambitions. The Bellevue, Wash., biotech thinks its lead program, Aptocine , a drug/device combination product...

Chemoprevention Agents Aim to Stop Skin Cancer Before It Starts

MG Sullivan, 2010 Aug 26, Elsevier Global Medical News

CHICAGO (EGMN) - In the not-too distant future, dermatologists may be sending patients off to the beach with a bagful of chemoprevention tricks to outwit ultraviolet radiation and reduce the risk of sun-related...

NICE Rejects Bevacizumab for Bowel Cancer

J Smith, 2010 Aug 24, Elsevier Global Medical News

The clinical effectiveness agency for England and Wales says that it will not recommend bevacizumab for the first-line treatment of metastatic colorectal cancer, despite fresh efforts by the manufacturer...

Pfizer Seeks to Salvage Sutent for Lung Cancer

E Hayes, 2010 Aug 24, The Pink Sheet Daily

Pfizer is exploring a possible role for its top-selling multi-targeted tyrosine kinase inhibitor Sutent (sunitinib) in subsets of patients with non-small cell lung cancer after the drug failed to meet...

PLX4032 May Clear Path for Individualized Treatment of Metastatic Melanoma

MG Sullivan, 2010 Aug 20, Elsevier Global Medical News

Chicago -- A drug that targets metastatic melanoma with mutations in the BRAF oncogene may be the first step on a path to individualized chemotherapy for patients with these formerly untreatable cancers....